Dr. Brent Christopher Kelly, MD

Dr. Kelly practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Kelly's NPI, 1992863765, was assigned on December 5, 2006. Dr. Kelly graduated from LSU Health Sciences Center New Orleans - School of Medicine in 1999. Dr. Kelly holds Texas license L4486.

Dr. Kelly's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Kelly's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice. Dmand AI also links Dr. Kelly to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kelly practices. Vendor and product names are available with a free account.

Dermatology is Dr. Kelly's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Kelly is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Kelly's licenses on file in 5 states: Texas, Florida, Oklahoma, Washington and Hawaii.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, rash, scalp rash and shingles among the conditions Dr. Kelly treats.

CMS data shows 2,119 Medicare services from Dr. Kelly across 13 procedure codes in 2024, for 688 Medicare patients. Medicare paid $49,803 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 688 Medicare patients who saw Dr. Kelly in 2024. The largest group is 65 to 74, with 339 patients. 72% of them have high blood pressure, and 70% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kelly's median patient age at 70, with 49% women.

In 2024, Dr. Kelly wrote 76 Medicare Part D claims for 35 patients. 75% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $69,165 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Kelly for performance year 2024, reported as part of a group. Dr. Kelly accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 419 procedures of removal of skin lesions by Dr. Kelly, more than 85% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 82 papers to Dr. Kelly, published from 2008 to 2025. 2016 was the busiest year, with 6. The most frequent topics are Skin, Skin Neoplasms and Diagnosis, Differential. Dr. Kelly has published most often in J Am Acad Dermatol. Dr. Kelly's most frequent co-authors are Richard F. Wagner, MD, Audra L. Clos, MD and Bernard R. Gibson, MD.

CMS Open Payments shows 2 general payments to Dr. Kelly from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 55% of the total. Bausch Health Americas, Inc. paid the most, $100.

Dmand AI lists 2 awards for Dr. Kelly, most recently CMS Stage 1 EHR in 2013.

Dr. Kelly graduated from LSU Health Sciences Center New Orleans - School of Medicine in 1999. Dr. Kelly is a member of AAD.

Dr. Kelly is in network with 22 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.